Prevail Therapeutics Inc.
Prevail Therapeutics Inc. (PRVL) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 19 transactions totaling $816.4M, demonstrating a bullish sentiment with $816.4M in net insider flow. The most recent transaction on Jan 22, 2021 involved a purchase of 34,284,789 shares valued at $771.4M.
PRVL Insider Activity Summary
Who Is Buying PRVL Stock?
No significant insider buying has been recorded for PRVL in the recent period.
Who Is Selling PRVL Stock?
No significant insider selling has been recorded for PRVL in the recent period.
Is Prevail Therapeutics Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PRVL is bullish with an Insider Alignment Score of 100/100 and a net flow of $816.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
PRVL Frequently Asked Questions
Understanding PRVL Insider Activity
Insider trading at Prevail Therapeutics Inc. (PRVL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading PRVL stock, having executed 19 transactions in the past 90 days. The most active insider is Acquisition Corp Tyto (Executive), who has made 1 transactions totaling $771.4M.
Related Tools
Track Prevail Therapeutics Inc. Insider Activity
Get notified when executives and directors at PRVL file new Form 4 transactions